Login
Home
Charts
Search
Watchlist
Products

Sanofi Consumer Healthcare India Ltd

SANOFICONR·NSE
₹3,989.00-0.10%Wed, 23 Sept '26 13:35
Industry:Pharma - MNC bulk Drugs
Indices:

Sanofi Consumer Healthcare India Ltd

SANOFICONR
NSE
₹3,989.00
-0.10%
|Wed, 23 Sept '26 13:35
SOICxStockScans Reports
Industry
Pharma - MNC bulk Drugs
Indices
View
Financials
Documents
Shareholdings
Corporate Actions
Segments
Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Peer Comparison
Financials
Documents
Shareholdings
Corporate Actions
Segments
Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Peer Comparison
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹9,187Cr
Close
Close Price
₹3,989.00
Industry
Industry
Pharma - MNC bulk Drugs
PE
Price To Earnings
34.54
PS
Price To Sales
9.67
Revenue
Revenue
₹950Cr
Rev Gr TTM
Revenue Growth TTM
31.17%
PAT Gr TTM
PAT Growth TTM
33.00%

Quarterly Results

Standalone
Numbers
Percentage
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
210225222172160171173221234251229236
Growth YoY
Revenue Growth YoY%
-24.0-24.0-22.128.246.347.032.86.7
Expenses
ExpensesCr
11613514010997109109151149161140146
Operating Profit
Operating ProfitCr
959082646362647085908989
OPM
OPM%
45.039.936.936.939.536.437.131.836.335.838.737.9
Other Income
Other IncomeCr
113-24325123566
Interest Expense
Interest ExpenseCr
000030011110
Depreciation
DepreciationCr
111121233333
PBT
PBTCr
959084396163677984919192
Tax
TaxCr
242221101619171821242323
PAT
PATCr
716863294544506163676869
Growth YoY
PAT Growth YoY%
-36.8-34.8-20.3109.339.850.135.613.3
NPM
NPM%
33.930.228.316.828.125.929.027.526.926.529.629.2
EPS
EPS₹
30.930.327.223.119.519.321.726.427.328.929.429.9
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
210225222172160171173221234251229236
Growth YoY
Revenue Growth YoY%
-24.0-24.0-22.128.246.347.032.86.7
Expenses
ExpensesCr
11613514010997109109151149161140146
Operating Profit
Operating ProfitCr
959082646362647085908989
OPM
OPM%
45.039.936.936.939.536.437.131.836.335.838.737.9
Other Income
Other IncomeCr
113-24325123566
Interest Expense
Interest ExpenseCr
000030011110
Depreciation
DepreciationCr
111121233333
PBT
PBTCr
959084396163677984919192
Tax
TaxCr
242221101619171821242323
PAT
PATCr
716863294544506163676869
Growth YoY
PAT Growth YoY%
-36.8-34.8-20.3109.339.850.135.613.3
NPM
NPM%
33.930.228.316.828.125.929.027.526.926.529.629.2
EPS
EPS₹
30.930.327.223.119.519.321.726.427.328.929.429.9

Profit & Loss

Standalone
Numbers
Percentage
Financial YearDec 2023Mar 2024Dec 2024Mar 2025Dec 2025TTM
Revenue
RevenueCr
555725725878878950
Growth
Revenue Growth%
30.421.221.231.2
Expenses
ExpensesCr
337454454569569597
Operating Profit
Operating ProfitCr
219271271309309353
OPM
OPM%
39.437.437.435.235.237.2
Other Income
Other IncomeCr
2-152520
Interest Expense
Interest ExpenseCr
044222
Depreciation
DepreciationCr
255121213
PBT
PBTCr
219247247320320357
Tax
TaxCr
546666808091
PAT
PATCr
165181181240240266
Growth
PAT Growth%
9.832.632.633.0
NPM
NPM%
29.725.025.027.327.328.0
EPS
EPS₹
71.678.6104.3104.3115.5
Financial YearDec 2023Mar 2024Dec 2024Mar 2025Dec 2025TTM
Revenue
RevenueCr
555725725878878950
Growth
Revenue Growth%
30.421.221.231.2
Expenses
ExpensesCr
337454454569569597
Operating Profit
Operating ProfitCr
219271271309309353
OPM
OPM%
39.437.437.435.235.237.2
Other Income
Other IncomeCr
2-152520
Interest Expense
Interest ExpenseCr
044222
Depreciation
DepreciationCr
255121213
PBT
PBTCr
219247247320320357
Tax
TaxCr
546666808091
PAT
PATCr
165181181240240266
Growth
PAT Growth%
9.832.632.633.0
NPM
NPM%
29.725.025.027.327.328.0
EPS
EPS₹
71.678.6104.3104.3115.5

Balance Sheet

Standalone
Numbers
Percentage
Financial YearDec 2023Dec 2024Dec 2025
Equity Capital
Equity CapitalCr
22323
Reserves
ReservesCr
183250361
Current Liabilities
Current LiabilitiesCr
130131128
Non Current Liabilities
Non Current LiabilitiesCr
82835
Total Liabilities
Total LiabilitiesCr
345431547
Current Assets
Current AssetsCr
335392494
Non Current Assets
Non Current AssetsCr
104053
Total Assets
Total AssetsCr
345431547
Financial YearDec 2023Dec 2024Dec 2025
Equity Capital
Equity CapitalCr
22323
Reserves
ReservesCr
183250361
Current Liabilities
Current LiabilitiesCr
130131128
Non Current Liabilities
Non Current LiabilitiesCr
82835
Total Liabilities
Total LiabilitiesCr
345431547
Current Assets
Current AssetsCr
335392494
Non Current Assets
Non Current AssetsCr
104053
Total Assets
Total AssetsCr
345431547

Cash Flow

Standalone
Financial YearDec 2023Mar 2024Dec 2024Dec 2025
Operating Cash Flow
Operating Cash FlowCr
0439439175
Investing Cash Flow
Investing Cash FlowCr
0228
Financing Cash Flow
Financing Cash FlowCr
2-116-116-135
Net Cash Flow
Net Cash FlowCr
232532548
Free Cash Flow
Free Cash FlowCr
-4429167
CFO To PAT
CFO To PAT%
-0.2242.5242.572.8
CFO To EBITDA
CFO To EBITDA%
-0.2162.2162.256.6
Financial YearDec 2023Mar 2024Dec 2024Dec 2025
Operating Cash Flow
Operating Cash FlowCr
0439439175
Investing Cash Flow
Investing Cash FlowCr
0228
Financing Cash Flow
Financing Cash FlowCr
2-116-116-135
Net Cash Flow
Net Cash FlowCr
232532548
Free Cash Flow
Free Cash FlowCr
-4429167
CFO To PAT
CFO To PAT%
-0.2242.5242.572.8
CFO To EBITDA
CFO To EBITDA%
-0.2162.2162.256.6

Ratios

Standalone
Financial YearDec 2023Mar 2024Dec 2024Mar 2025Dec 2025Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
11,34810,4249,187
Price To Earnings
Price To Earnings
62.643.434.5
Price To Sales
Price To Sales
15.711.99.7
Price To Book
Price To Book
41.527.126.4
EV To EBITDA
EV To EBITDA
40.832.624.8
Profitability Ratios
Profitability Ratios
GPM
GPM%
64.968.267.867.8
OPM
OPM%
39.437.437.435.235.237.2
NPM
NPM%
29.725.025.027.327.328.0
ROCE
ROCE%
118.885.578.878.8
ROE
ROE%
89.366.362.562.5
ROA
ROA%
47.742.043.943.9
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearDec 2023Mar 2024Dec 2024Mar 2025Dec 2025Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
11,34810,4249,187
Price To Earnings
Price To Earnings
62.643.434.5
Price To Sales
Price To Sales
15.711.99.7
Price To Book
Price To Book
41.527.126.4
EV To EBITDA
EV To EBITDA
40.832.624.8
Profitability Ratios
Profitability Ratios
GPM
GPM%
64.968.267.867.8
OPM
OPM%
39.437.437.435.235.237.2
NPM
NPM%
29.725.025.027.327.328.0
ROCE
ROCE%
118.885.578.878.8
ROE
ROE%
89.366.362.562.5
ROA
ROA%
47.742.043.943.9
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios

Documents — Sanofi Consumer Healthcare India Ltd

  • Q3 FY2026 Earnings Call Transcript (Dec 2025, PDF): https://www.stockscans.in/document/sib7kafs2oi080a5oa93e4hj.pdf
  • Q1 FY2027 Quarterly Result (Jun 2026, PDF): https://www.stockscans.in/document/4omz504vh8ji3st0czpgl5oy.pdf
  • Q4 FY2026 Quarterly Result (Mar 2026, PDF): https://www.stockscans.in/document/kl2g9us8xac20m08h2uc65w8.pdf
  • Q3 FY2026 Quarterly Result (Dec 2025, PDF): https://www.stockscans.in/document/s8iymgeksn6oj9odn6ckpqtp.pdf
  • Q2 FY2026 Quarterly Result (Sep 2025, PDF): https://www.stockscans.in/document/20zqrbfj30ndgs4hbpnri9yq.pdf
  • Q1 FY2026 Quarterly Result (Jun 2025, PDF): https://www.stockscans.in/document/qwo0qs9qinvqja4rnpfh8dd6.pdf
  • Q4 FY2025 Quarterly Result (Mar 2025, PDF): https://www.stockscans.in/document/b8xe11y6wrjak2bcw9wll72o.pdf
  • Q3 FY2025 Quarterly Result (Dec 2024, PDF): https://www.stockscans.in/document/purjtp199la5cylue3gdcpcs.pdf
  • Q2 FY2025 Quarterly Result (Sep 2024, PDF): https://www.stockscans.in/document/oqewgihuurza4sk5m3qge7up.pdf
  • Q3 FY2026 Investor Presentation (Dec 2025, PDF): https://www.stockscans.in/document/sjg2sbrhr7hvvror73pq3o5g.pdf
  • FY2026 Annual Report (PDF): https://www.stockscans.in/document/yfrudyvmxytks37y00ib0lgr.pdf
  • FY2025 Annual Report (PDF): https://www.stockscans.in/document/hoknmbbgvxdghqo72frw3ko6.pdf
  • FY2024 Annual Report (PDF): https://www.stockscans.in/document/b3tkwd6zpe1wmi7fh28fbrbq.pdf

Concall Transcript Summaries — Sanofi Consumer Healthcare India Ltd

  • Q3 FY2026 Concall Transcript Summary (Dec 2025): https://www.stockscans.in/company/NSE%3ASANOFICONR/transcript-notes/202512/sib7kafs2oi080a5oa93e4hj.pdf

Simplify stock analysis with powerful tools and clear insights for confident, data-driven decisions.

support@stockscans.in
© StockScans by SOIC Technologies Pvt Ltd
349 A, Lodhi Road, Punjabi Bazar, New DelhiData provided by CMOTS Internet Technologies